LRBA antisense RNA 1 (LRBA-AS1)

LRBA antisense RNA 1 (LRBA-AS1) is a long non-coding RNA (lncRNA) gene transcribed from the human genome and classified specifically as an antisense RNA[1]. Antisense lncRNAs such as LRBA-AS1 are synthesized from the DNA strand complementary to a coding or non-coding gene; in this case, LRBA-AS1 is antisense to the LRBA gene. Antisense lncRNAs frequently regulate gene expression at the transcriptional or post-transcriptional level, often by influencing the chromatin state, RNA stability, or transcriptional activity of their paired sense gene[2]. While many antisense lncRNAs can play roles in development, disease, and gene regulation, there is currently no direct evidence that LRBA-AS1 itself is used as a therapeutic target or approved biomarker in any disease context[1]. Information about direct drug interactions, mechanisms of pharmacological modulation, or associated safety concerns for LRBA-AS1 is unavailable or not established in the scientific literature as of this date. Notes: - The entry is not misspelled or incorrect; however, its functional and pathological roles remain largely uncharacterized in the literature. - General information about the function and potential roles of antisense lncRNAs is available, but specific details for LRBA-AS1 are not well documented[2][1]. - If future research identifies disease relevance or targeting strategies, the above structured information may need to be updated.

Other names

LRBA-AS1